tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Brian Cheng, 111 are a BUY (83.46%), 5 are a SELL (3.76%), 17 are a HOLD (12.78%).
Analyst Brian Cheng, currently employed at JPMORGAN, carries an average stock price target met ratio of 47.3% that have a potential upside of 24.14% achieved within 115 days.
Brian Cheng’s has documented 253 price targets and ratings displayed on 34 stocks. The coverage is on Healthcare, Utilities sectors.
Most recent stock forecast was given on XNCR, Xencor at 02-Sep-2026.
Analyst best performing recommendations are on CRGX (CARGO THERAPEUTICS, COMMON STOCK).
The best stock recommendation documented was for PTGX (PROTAGONIST THERAPEUTICS) at 3/4/2025. The price target of $57 was fulfilled within 7 days with a profit of $18.34 (47.44%) receiving and performance score of 67.77.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Jan-2025
$20
$6.15 (44.40%)
$23
7 days ago
(24-Sep-2026)
0/5 (0%)
$5.88 (41.64%)
Hold Since 13-Nov-2025
$20
$6.15 (44.40%)
$8
7 days ago
(24-Sep-2026)
7/14 (50%)
$5.88 (41.64%)
142
Buy Since 02-Jul-2026
$27
$13.15 (94.95%)
2 months 29 days ago
(02-Jul-2026)
0/1 (0%)
$19.72 (270.88%)
Hold Since 18-Mar-2026
$22
$8.15 (58.84%)
$23
6 months 13 days ago
(18-Mar-2026)
6/9 (66.67%)
$15.45 (235.88%)
99
Buy Since 07-Feb-2020
$21
$7.15 (51.62%)
6 months 26 days ago
(05-Mar-2026)
1/9 (11.11%)
$13.75 (189.66%)
75
Which stock is Brian Cheng most bullish on?
Which stock is Brian Cheng most reserved on?
What Year was the first public recommendation made by Brian Cheng?
